The latter data are in line with our study, which found significantly lower protein levels of ALKBH3 in GBM compared to the healthy brain parenchyma, as well as an association of the ALKBH3low phenotype with a short OS of the GBM patients. This evidence concerns the gene ALKBH3 and glioblastoma.